CalciMedica (CALC) Competitors $1.93 -0.06 (-3.02%) As of 12:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CALC vs. COYA, CHRS, MIST, FATE, PROC, NKTX, XBIT, SLN, IMUX, and GALTShould you be buying CalciMedica stock or one of its competitors? The main competitors of CalciMedica include Coya Therapeutics (COYA), Coherus BioSciences (CHRS), Milestone Pharmaceuticals (MIST), Fate Therapeutics (FATE), Procaps Group (PROC), Nkarta (NKTX), XBiotech (XBIT), Silence Therapeutics (SLN), Immunic (IMUX), and Galectin Therapeutics (GALT). These companies are all part of the "pharmaceutical products" industry. CalciMedica vs. Coya Therapeutics Coherus BioSciences Milestone Pharmaceuticals Fate Therapeutics Procaps Group Nkarta XBiotech Silence Therapeutics Immunic Galectin Therapeutics CalciMedica (NASDAQ:CALC) and Coya Therapeutics (NASDAQ:COYA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Which has stronger valuation & earnings, CALC or COYA? Coya Therapeutics has higher revenue and earnings than CalciMedica. Coya Therapeutics is trading at a lower price-to-earnings ratio than CalciMedica, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalciMedicaN/AN/A-$34.36M-$1.19-1.62Coya Therapeutics$3.55M30.85-$7.99M-$0.98-6.69 Does the media refer more to CALC or COYA? In the previous week, Coya Therapeutics had 7 more articles in the media than CalciMedica. MarketBeat recorded 11 mentions for Coya Therapeutics and 4 mentions for CalciMedica. CalciMedica's average media sentiment score of 1.22 beat Coya Therapeutics' score of 0.90 indicating that CalciMedica is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CalciMedica 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Coya Therapeutics 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CALC or COYA more profitable? Coya Therapeutics' return on equity of -31.63% beat CalciMedica's return on equity.Company Net Margins Return on Equity Return on Assets CalciMedicaN/A -164.24% -103.53% Coya Therapeutics N/A -31.63%-27.76% Does the MarketBeat Community prefer CALC or COYA? Coya Therapeutics received 7 more outperform votes than CalciMedica when rated by MarketBeat users. Likewise, 95.83% of users gave Coya Therapeutics an outperform vote while only 94.12% of users gave CalciMedica an outperform vote. CompanyUnderperformOutperformCalciMedicaOutperform Votes1694.12% Underperform Votes15.88%Coya TherapeuticsOutperform Votes2395.83% Underperform Votes14.17% Do analysts recommend CALC or COYA? CalciMedica currently has a consensus target price of $18.00, indicating a potential upside of 832.64%. Coya Therapeutics has a consensus target price of $17.00, indicating a potential upside of 159.34%. Given CalciMedica's higher probable upside, equities analysts plainly believe CalciMedica is more favorable than Coya Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CalciMedica 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Coya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in CALC or COYA? 39.8% of Coya Therapeutics shares are owned by institutional investors. 41.5% of CalciMedica shares are owned by insiders. Comparatively, 12.0% of Coya Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, CALC or COYA? CalciMedica has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Coya Therapeutics has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500. SummaryCoya Therapeutics beats CalciMedica on 10 of the 15 factors compared between the two stocks. Remove Ads Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CALC vs. The Competition Export to ExcelMetricCalciMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.02M$6.87B$5.62B$7.73BDividend YieldN/A2.80%5.33%4.02%P/E Ratio-1.797.3523.5418.59Price / SalesN/A206.32371.7888.87Price / CashN/A65.6738.1734.64Price / Book1.366.216.824.11Net Income-$34.36M$142.11M$3.20B$247.18M7 Day Performance-7.21%-8.48%-5.42%-3.93%1 Month Performance-13.06%-10.09%-0.14%-6.33%1 Year Performance-53.61%-12.81%7.96%-1.93% CalciMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CALCCalciMedica2.4919 of 5 stars$1.93-3.0%$18.00+832.6%-52.2%$26.02MN/A-1.7930Earnings ReportGap UpCOYACoya Therapeutics2.0382 of 5 stars$6.65-0.4%$17.00+155.6%-33.9%$111.22M$3.55M-10.236CHRSCoherus BioSciences3.6799 of 5 stars$0.95-7.6%$5.38+464.5%-64.9%$110.35M$266.96M-11.90330Gap DownMISTMilestone Pharmaceuticals2.3024 of 5 stars$2.05+7.9%$17.00+729.3%-50.8%$109.38M$1M-2.5330Analyst ForecastHigh Trading VolumeFATEFate Therapeutics3.8731 of 5 stars$0.94+2.9%$5.50+484.6%-88.4%$107.81M$13.63M-0.57550Positive NewsGap DownPROCProcaps GroupN/A$0.95-40.3%N/A-67.2%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeNKTXNkarta2.6494 of 5 stars$1.55+3.3%$15.00+867.7%-81.5%$105.85MN/A-0.82140Earnings ReportAnalyst RevisionNews CoverageGap DownXBITXBiotech1.2273 of 5 stars$3.46+0.6%N/A-61.9%$105.49M$4.01M-3.20100Short Interest ↓News CoveragePositive NewsGap UpSLNSilence Therapeutics2.0914 of 5 stars$3.49-2.0%$40.67+1,065.2%-84.1%$104.46M$43.26M-2.22100Positive NewsGap DownIMUXImmunic2.6069 of 5 stars$1.17+1.7%$12.67+982.6%-9.1%$103.59MN/A-0.9570News CoverageGALTGalectin Therapeutics1.1551 of 5 stars$1.65+3.8%$11.00+566.7%-36.4%$103.56MN/A-2.269Earnings ReportUpcoming EarningsNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies Coya Therapeutics Alternatives Coherus BioSciences Alternatives Milestone Pharmaceuticals Alternatives Fate Therapeutics Alternatives Procaps Group Alternatives Nkarta Alternatives XBiotech Alternatives Silence Therapeutics Alternatives Immunic Alternatives Galectin Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CALC) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CALC Stock Free CALC Stock Alerts